Selected research
Industry Research
Specific IgE Blood Based Allergy Testing Industry Research Report 2026
Market perspective
The global Specific IgE Blood Based Allergy Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Specific IgE Blood Based Allergy Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Specific IgE Blood Based Allergy Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Specific IgE Blood Based Allergy Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Specific IgE Blood Based Allergy Testing include Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis and Omega Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Specific IgE Blood Based Allergy Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Specific IgE Blood Based Allergy Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Specific IgE Blood Based Allergy Testing Market by Company
Phadia (Thermo Fisher Scientific)
Medwiss Analytic
Euroimmun
Quest Diagnostics
Eurofins Biomnis
Siemens Healthineers
Labcorp
Novartis
Omega Diagnostics
Minaris Medical America
MacroArray Diagnostics
DST
HYCOR Biomedical
Everlywell
Abionic
Diagnostic Solutions Laboratory
MosaicDX
Lifelab Testing
HOB Biotech Group
Shenzhen Biocup Biotech
Hangzhou Zheda Dixun Biological Gene Engineering
ACON Biotech
Specific IgE Blood Based Allergy Testing Segment by Type
ELISA
FEIA
Others
Specific IgE Blood Based Allergy Testing Segment by Application
Hospitals
Clinics
Clinical Laboratories
Others
Specific IgE Blood Based Allergy Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specific IgE Blood Based Allergy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Specific IgE Blood Based Allergy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specific IgE Blood Based Allergy Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Specific IgE Blood Based Allergy Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA
- FEIA
- Others
Applications
- Hospitals
- Clinics
- Clinical Laboratories
- Others
Companies covered
- Phadia (Thermo Fisher Scientific)
- Medwiss Analytic
- Euroimmun
- Quest Diagnostics
- Eurofins Biomnis
- Siemens Healthineers
- Labcorp
- Novartis
- Omega Diagnostics
- Minaris Medical America
- MacroArray Diagnostics
- DST
- HYCOR Biomedical
- Everlywell
- Abionic
- Diagnostic Solutions Laboratory
- MosaicDX
- Lifelab Testing
- HOB Biotech Group
- Shenzhen Biocup Biotech
- Hangzhou Zheda Dixun Biological Gene Engineering
- ACON Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Specific IgE Blood Based Allergy Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ELISA
- 2.2.3 FEIA
- 2.2.4 Others
- 2.3 Specific IgE Blood Based Allergy Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Clinical Laboratories
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Specific IgE Blood Based Allergy Testing Breakdown Data by Type
- 3.1 Global Specific IgE Blood Based Allergy Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Specific IgE Blood Based Allergy Testing Forecasted Market Size by Type (2027-2032)
4 Specific IgE Blood Based Allergy Testing Breakdown Data by Application
- 4.1 Global Specific IgE Blood Based Allergy Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Specific IgE Blood Based Allergy Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Specific IgE Blood Based Allergy Testing Market Perspective (2021-2032)
- 5.2 Global Specific IgE Blood Based Allergy Testing Growth Trends by Region
- 5.2.1 Global Specific IgE Blood Based Allergy Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Specific IgE Blood Based Allergy Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Specific IgE Blood Based Allergy Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Specific IgE Blood Based Allergy Testing Market Dynamics
- 5.3.1 Specific IgE Blood Based Allergy Testing Industry Trends
- 5.3.2 Specific IgE Blood Based Allergy Testing Market Drivers
- 5.3.3 Specific IgE Blood Based Allergy Testing Market Challenges
- 5.3.4 Specific IgE Blood Based Allergy Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Specific IgE Blood Based Allergy Testing Players by Revenue
- 6.1.1 Global Top Specific IgE Blood Based Allergy Testing Players by Revenue (2021-2026)
- 6.1.2 Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Specific IgE Blood Based Allergy Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Specific IgE Blood Based Allergy Testing Head Office and Area Served
- 6.4 Global Specific IgE Blood Based Allergy Testing Players, Product Type & Application
- 6.5 Global Specific IgE Blood Based Allergy Testing Manufacturers Established Date
- 6.6 Global Specific IgE Blood Based Allergy Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
- 7.2 North America Specific IgE Blood Based Allergy Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Specific IgE Blood Based Allergy Testing Market Size by Country (2021-2026)
- 7.4 North America Specific IgE Blood Based Allergy Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
- 8.2 Europe Specific IgE Blood Based Allergy Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Specific IgE Blood Based Allergy Testing Market Size by Country (2021-2026)
- 8.4 Europe Specific IgE Blood Based Allergy Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Specific IgE Blood Based Allergy Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Specific IgE Blood Based Allergy Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Specific IgE Blood Based Allergy Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
- 10.2 South America Specific IgE Blood Based Allergy Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Specific IgE Blood Based Allergy Testing Market Size by Country (2021-2026)
- 10.4 South America Specific IgE Blood Based Allergy Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Specific IgE Blood Based Allergy Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Specific IgE Blood Based Allergy Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Specific IgE Blood Based Allergy Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Phadia (Thermo Fisher Scientific)
- 12.1.1 Phadia (Thermo Fisher Scientific) Company Information
- 12.1.2 Phadia (Thermo Fisher Scientific) Business Overview
- 12.1.3 Phadia (Thermo Fisher Scientific) Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.1.4 Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.1.5 Phadia (Thermo Fisher Scientific) Recent Developments
- 12.2 Medwiss Analytic
- 12.2.1 Medwiss Analytic Company Information
- 12.2.2 Medwiss Analytic Business Overview
- 12.2.3 Medwiss Analytic Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.2.4 Medwiss Analytic Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.2.5 Medwiss Analytic Recent Developments
- 12.3 Euroimmun
- 12.3.1 Euroimmun Company Information
- 12.3.2 Euroimmun Business Overview
- 12.3.3 Euroimmun Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.3.4 Euroimmun Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.3.5 Euroimmun Recent Developments
- 12.4 Quest Diagnostics
- 12.4.1 Quest Diagnostics Company Information
- 12.4.2 Quest Diagnostics Business Overview
- 12.4.3 Quest Diagnostics Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.4.4 Quest Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.4.5 Quest Diagnostics Recent Developments
- 12.5 Eurofins Biomnis
- 12.5.1 Eurofins Biomnis Company Information
- 12.5.2 Eurofins Biomnis Business Overview
- 12.5.3 Eurofins Biomnis Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.5.4 Eurofins Biomnis Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.5.5 Eurofins Biomnis Recent Developments
- 12.6 Siemens Healthineers
- 12.6.1 Siemens Healthineers Company Information
- 12.6.2 Siemens Healthineers Business Overview
- 12.6.3 Siemens Healthineers Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.6.4 Siemens Healthineers Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.6.5 Siemens Healthineers Recent Developments
- 12.7 Labcorp
- 12.7.1 Labcorp Company Information
- 12.7.2 Labcorp Business Overview
- 12.7.3 Labcorp Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.7.4 Labcorp Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.7.5 Labcorp Recent Developments
- 12.8 Novartis
- 12.8.1 Novartis Company Information
- 12.8.2 Novartis Business Overview
- 12.8.3 Novartis Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.8.4 Novartis Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.8.5 Novartis Recent Developments
- 12.9 Omega Diagnostics
- 12.9.1 Omega Diagnostics Company Information
- 12.9.2 Omega Diagnostics Business Overview
- 12.9.3 Omega Diagnostics Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.9.4 Omega Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.9.5 Omega Diagnostics Recent Developments
- 12.10 Minaris Medical America
- 12.10.1 Minaris Medical America Company Information
- 12.10.2 Minaris Medical America Business Overview
- 12.10.3 Minaris Medical America Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.10.4 Minaris Medical America Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.10.5 Minaris Medical America Recent Developments
- 12.11 MacroArray Diagnostics
- 12.11.1 MacroArray Diagnostics Company Information
- 12.11.2 MacroArray Diagnostics Business Overview
- 12.11.3 MacroArray Diagnostics Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.11.4 MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.11.5 MacroArray Diagnostics Recent Developments
- 12.12 DST
- 12.12.1 DST Company Information
- 12.12.2 DST Business Overview
- 12.12.3 DST Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.12.4 DST Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.12.5 DST Recent Developments
- 12.13 HYCOR Biomedical
- 12.13.1 HYCOR Biomedical Company Information
- 12.13.2 HYCOR Biomedical Business Overview
- 12.13.3 HYCOR Biomedical Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.13.4 HYCOR Biomedical Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.13.5 HYCOR Biomedical Recent Developments
- 12.14 Everlywell
- 12.14.1 Everlywell Company Information
- 12.14.2 Everlywell Business Overview
- 12.14.3 Everlywell Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.14.4 Everlywell Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.14.5 Everlywell Recent Developments
- 12.15 Abionic
- 12.15.1 Abionic Company Information
- 12.15.2 Abionic Business Overview
- 12.15.3 Abionic Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.15.4 Abionic Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.15.5 Abionic Recent Developments
- 12.16 Diagnostic Solutions Laboratory
- 12.16.1 Diagnostic Solutions Laboratory Company Information
- 12.16.2 Diagnostic Solutions Laboratory Business Overview
- 12.16.3 Diagnostic Solutions Laboratory Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.16.4 Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.16.5 Diagnostic Solutions Laboratory Recent Developments
- 12.17 MosaicDX
- 12.17.1 MosaicDX Company Information
- 12.17.2 MosaicDX Business Overview
- 12.17.3 MosaicDX Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.17.4 MosaicDX Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.17.5 MosaicDX Recent Developments
- 12.18 Lifelab Testing
- 12.18.1 Lifelab Testing Company Information
- 12.18.2 Lifelab Testing Business Overview
- 12.18.3 Lifelab Testing Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.18.4 Lifelab Testing Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.18.5 Lifelab Testing Recent Developments
- 12.19 HOB Biotech Group
- 12.19.1 HOB Biotech Group Company Information
- 12.19.2 HOB Biotech Group Business Overview
- 12.19.3 HOB Biotech Group Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.19.4 HOB Biotech Group Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.19.5 HOB Biotech Group Recent Developments
- 12.20 Shenzhen Biocup Biotech
- 12.20.1 Shenzhen Biocup Biotech Company Information
- 12.20.2 Shenzhen Biocup Biotech Business Overview
- 12.20.3 Shenzhen Biocup Biotech Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.20.4 Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.20.5 Shenzhen Biocup Biotech Recent Developments
- 12.21 Hangzhou Zheda Dixun Biological Gene Engineering
- 12.21.1 Hangzhou Zheda Dixun Biological Gene Engineering Company Information
- 12.21.2 Hangzhou Zheda Dixun Biological Gene Engineering Business Overview
- 12.21.3 Hangzhou Zheda Dixun Biological Gene Engineering Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.21.4 Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.21.5 Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
- 12.22 ACON Biotech
- 12.22.1 ACON Biotech Company Information
- 12.22.2 ACON Biotech Business Overview
- 12.22.3 ACON Biotech Revenue in Specific IgE Blood Based Allergy Testing Business (2021-2026)
- 12.22.4 ACON Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
- 12.22.5 ACON Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst